Antikörper gegen OPGL

Patent europeic · EP2295081 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2295081
Numer da la dumonda
EP10185344
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-06-2002
Publitgà
16-03-2011
Concedì
31-10-2018
Stritgà
01-07-2022
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 39/395 (2006.01)
G01N 33/53 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 301172 P 26.06.2001
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2022

    Durada maximala cuntanschida

    Published in Swissreg on 01.07.2022

  2. 20-03-2019

    Adressa midada

    Representative
    Valipat S.A., Gevers SA, Rue des Noyers 11, 2000 Neuchâtel → Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 20.03.2019

  3. 31-01-2019

    Represchentant inscrit

    Representative
    Valipat S.A., Gevers SA, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 31.01.2019

  4. 31-10-2018

    Concedì

    Published in Swissreg on 31.10.2018

Partidas

Inventur

Davis, Geoffrey

Auburn, CA 95602, US

Martin, Francis

Newbury Park, CA 91320, US

Boyle, William

Malibu, CA 90265, US

Corvalan, Jose

Foster City, CA 94404, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.